Brian H Nathanson
Overview
Explore the profile of Brian H Nathanson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
158
Citations
1547
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Presti T, Nathanson B, Schlecht H, Steingrub J, DiNino E
Brown J Hosp Med
. 2025 Mar;
2(1):39621.
PMID: 40046554
Background: It remains unknown to what degree lung physiology is altered by administration of convalescent plasma in patients intubated with ARDS due to COVID-19 pneumonia. Although no longer clinically used...
2.
Zilberberg M, Nathanson B, Redell M, Sulham K, Shorr A
Antibiotics (Basel)
. 2025 Jan;
14(1).
PMID: 39858315
: Meropenem-vaborbactam (MEV) and ceftazidime-avibactam (CZA) are active against "urgent threat" pathogens like carbapenem-resistant Enterobacterales (CRE). However, few studies have compared outcomes between them. : To explore comparative outcomes of...
3.
Marcus R, Miller D, Nathanson B, Eckhardt D, Henry S, Kwon K, et al.
Am J Manag Care
. 2025 Jan;
30(12):e345-e351.
PMID: 39745500
Objective: To determine whether an intensive value-based care educational program that includes a standardized end-stage renal disease (ESRD) transition pathway would improve the number of optimal starts within Kidney Contracting...
4.
Adler A, Bryant B, Baszynski D, Lee A, Medellin E, Nathanson B, et al.
J Opioid Manag
. 2024 Nov;
20(5):355-364.
PMID: 39545440
Background: Opioids are a mainstay in treating acute post-surgical pain although there are limited data on post-discharge use. Objectives: To assess post-operative opioid usage in children undergoing outpatient pediatric surgical...
5.
Dubberke E, Li Q, Obi E, Turzhitsky V, Siddiqui F, Nathanson B
Open Forum Infect Dis
. 2024 Oct;
11(10):ofae524.
PMID: 39355263
Background: The 2021 update to the Infectious Diseases Society of America infection (CDI) guidelines recommended fidaxomicin as the preferred treatment over vancomycin for patients with initial and recurrent CDI. Few...
6.
Soundararajan K, Adams D, Nathanson B, Mader T, Godwin R, Melvin R, et al.
Acad Emerg Med
. 2024 Sep;
32(2):169-171.
PMID: 39300690
No abstract available.
7.
Vital C, Peterson C, Benjamin E, Naglieri-Prescod D, Faron P, Nathanson B
J Holist Nurs
. 2024 Sep;
:8980101241277050.
PMID: 39279499
Specialty nursing certifications serve as a validation of nursing knowledge in specific areas. Holistic nursing emphasizes comprehensive patient care and incorporates complementary alternative modalities (CAM) into daily care. Despite its...
8.
Lodise T, Obi E, Watanabe A, Yucel E, Min J, Nathanson B
J Antimicrob Chemother
. 2024 Sep;
79(11):2954-2964.
PMID: 39258877
Background: Ceftolozane/tazobactam and ceftazidime/avibactam are commonly used in patients with MDR-Pseudomonas aeruginosa (PSA) pneumonia (PNA). This study compared outcomes between non-COVID-19 hospitalized patients with MDR-PSA PNA who received ceftolozane/tazobactam or...
9.
Coute R, Kons H, Nathanson B, Richardson J, Ferguson W, Jackson E
Circ Cardiovasc Qual Outcomes
. 2024 Jun;
17(7):e010907.
PMID: 38828564
No abstract available.
10.
Coute R, Nathanson B, Shekhar A, White C, Kurz M, Jackson E, et al.
Prehosp Emerg Care
. 2024 Mar;
:1-7.
PMID: 38451237
Objective: To calculate disability-adjusted life years (DALY) and labor productivity loss due to drug overdose out-of-hospital cardiac arrest (DO-OHCA) and compare its contribution to the burden of disease and economic...